D-0622-2018 Class II Terminated
FDA drug recall D-0622-2018 was initiated by Elroselabs Inc. on March 28, 2018 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated December 15, 2020). Affected quantity: Unknown.
Recall Details
- Product Type
- Drugs
- Report Date
- April 18, 2018
- Initiation Date
- March 28, 2018
- Termination Date
- December 15, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Unknown
Product Description
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
Reason for Recall
cGMP Deviations
Distribution Pattern
Nationwide.
Code Information
All product within expiry